INTERNATIONAL PATENT: TRAVERE THERAPEUTICS, INC. FILES APPLICATION FOR "SPARSENTAN FOR TREATING IMMUNOGLOBULIN A NEPHROPATHY (IGAN)"

GENEVA, April 2 -- TRAVERE THERAPEUTICS, INC. (3611 Valley Centre Drive, Suite 300San Diego, California 92130) filed a patent application (PCT/US2024/047507) for "SPARSENTAN FOR TREATING IMMUNOGLOBULIN A NEPHROPATHY (IGAN)" on Sep 19, 2024. With publication no. WO/2025/064688, the details related to the patent application was published on Mar 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KOMERS, Radko (c/o Travere Therapeutics, Inc.3611 Valley Centre Drive, Suite 300San Diego, California 92130)

Abstract: Methods of treating immunoglobulin A nephropathy are provided, including method...